Search
for
Sort by
Research 601–630 of 1000+
- Telogen effluvium, Beau lines, and acral peeling associated with COVID-19 infection
- Alert to US physicians: DHEA, widely used as an OTC androgen supplement, may exacerbate COVID-19
- Caution in the time of rashes and COVID-19
- Preliminary Investigation on Micro-Needling with Low-Level LED Therapy and Growth Factors in Hair Loss Related to COVID-19
- Association Between Hair Diseases and COVID-19 Pandemic-Related Stress: A Cross-Sectional Study Analysis
- Correlation Between Interest in COVID-19 Hair Loss and COVID-19 Surges: Analysis of Google Trends
- COVID-19 Infection Induce miR-371a-3p Upregulation Resulting in Influence on Male Fertility
- Male balding as a major risk factor for severe COVID-19: A possible role for targeting androgens and transmembrane protease serine 2 to protect vulnerable individuals
- COVID-19 lockdown and beyond: Home practice solutions for developing microsurgical skills.
- Androgenetic alopecia in COVID-19: Compared to what?
- Evaluating the Predictors of Persistent Long COVID Symptoms and Their Severity in COVID-19 Survivors 1 Year After Infection
- Covid induced telogen effluvium (CITE): An insight
- Skin Diseases Associated With COVID-19: A Narrative Review
- Evaluation of patients with telogen effluvium during the pandemic: May the monocytes be responsible for post COVID‐19 telogen effluvium?
- Clinical, laboratory and psychological aspects of moderate COVID-19 in cardiovascular patients one month after discharge from the hospital
- Alopecia and severity of COVID-19: a cross-sectional study in Peru
- Comment on “Androgenetic alopecia present in the majority of patients hospitalized with COVID-19”
- Cepharanthine: A review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- Impact of anti-androgen therapies on COVID-19 susceptibility: a case-control study in male population from two COVID-19 regional centers of Lombardy (Italy)
- Alopecia Areata after COVID-19 Vaccines
- The effect of COVID‐19 on development of hair and nail disorders: a Turkish multicenter, controlled study
- Hair Loss and Telogen Effluvium Related to COVID-19: The Potential Implication of Adipose-Derived Mesenchymal Stem Cells and Platelet-Rich Plasma as Regenerative Strategies
- COVID-19 patients at referral to hospital during the first peak of disease: Common clinical findings including myalgia and fatigue
- Diagnosis of stress-associated dermatologic conditions in New York City safety-net hospitals during the COVID-19 pandemic
- Ultrastructural evidence for anagen hair follicle infection with SARS‐CoV‐2 in early‐onset COVID‐19 effluvium
- Complementary Strategies to Promote Hair Regrowth in Post-COVID-19 Telogen Effluvium
- Relationship between hair shedding and systemic inflammation in COVID-19 pneumonia
- Androgenetic alopecia and COVID‐19: Is there a clinical connection?
- Indirect skin sign of COVID‐19 days: Striae rubrae
- Persistent or new symptoms 1 year after a single high dose of vitamin D3 in patients with moderate to severe COVID-19